PGR and invasive breast carcinoma: Our finding that progesterone receptor (PR) positivity was associated with significantly decreased HR for death among the TCGA cohort of TP53 DNA BD MM BrCa patients is consistent with a previous report that TP53 mutant/PR negative BrCa patients had decreased survival compared to TP53 mutant/PR positive patients [18].